OLMA — Olema Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Olema Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -71.1 | -105 | -96.7 | -129 | -162 |
| Depreciation | |||||
| Non-Cash Items | 17.4 | 19.3 | 13.1 | 15.6 | 12.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.83 | 3.02 | -0.589 | 9.16 | 2.77 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -50.7 | -82.1 | -83.7 | -104 | -147 |
| Capital Expenditures | -1.57 | -0.363 | 0 | -0.159 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -274 | 91.8 | -4.85 | -93.4 | -156 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -275 | 91.5 | -4.85 | -93.5 | -156 |
| Financing Cash Flow Items | — | — | 130 | 244 | -6.51 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.39 | 0.476 | 133 | 269 | 211 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -325 | 9.89 | 44.8 | 70.9 | -91.2 |